自燃式纳米细菌生物混合物重编程 内瘤口腔微生物群免疫相互作用用于癌症免疫疗法
Yueru Pang1, Ruixin Kang1, Ziqi Shen1
1Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.
概括
这项研究介绍了LYC@Bac,这是一种新的系统,可以消除像Fusobacterium nucleatum (Fn) 这样的免疫抑制细菌,并激活自然杀手 (NK) 细胞. 这种方法通过重编程瘤微环境 (TME) 来增强癌症免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物组研究 微生物组研究
背景情况:
- 癌症免疫疗法的有效性受到瘤微环境 (TME) 微生物群-免疫细胞相互作用的限制.
- 菌核素 (Fn) 抑制免疫细胞,特别是自然杀手 (NK) 细胞,阻碍抗瘤反应.
研究的目的:
- 开发一种生物混合系统 (LYC@Bac),同时针对Fn并激活TME内的NK细胞.
- 通过调节微生物群-免疫轴来增强癌症免疫疗法.
主要方法:
- 设计了一个纳米细菌生物混合系统 (LYC@Bac),结合了IL-15表达益生菌 (Bac) 和pH敏感的酶纳米粒子 (LYC).
- 利用酸性TME触发溶酶释放,溶解Fn并释放PAMP来激活树突细胞.
- 从溶解的Bac中促进IL-15的释放,通过mTOR途径激活NK细胞,升调NKG2D并增强细胞毒性作用因子分泌.
主要成果:
- LYC@Bac有效地消除了TME中的Fn,减少了免疫抑制.
- 激活的NK细胞表现出增强的抗瘤免疫力和对Fn.的抗菌功能.
- 建立了一个积极的反循环,加剧NK细胞介导的瘤清除和Fn根除.
结论:
- 该LYC@Bac生物混合系统精确地调节了内微生物群和免疫细胞的交叉通话.
- 这一策略提供了一种有前途的方法,通过向TME内的细菌和免疫成分来增强癌症免疫治疗结果.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Microorganisms in Medicine and Therapeutics
917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917


